Skip to main content

Table 1 Summary of hepatic metastasectomy from selected studies

From: Oligometastasis and oligo-recurrence: more than a mirage

Primary tumor type Year No. patients 5-year survival (%) 10-year survival (%) References
Noncolorectal 2005 142 26 / [16]
Noncolorectal Nonendocrine liver metastases 2006 1452 36 23 [17]
Noncolorectal nonneuroendocrine liver metastases 2007 360 37 / [18]
Breast cancer 2010 41 48 / [19]
Soft-tissue sarcoma 2009 45 49 / [20]